SAM Special Notice_S25-104 Malaria Vaccine Immunogenicity.pdf
PDF 215 KB Posted
- Attached to
- NCI OA Special Notice of Subcontract Opportunity at the Frederick National Laboratory for Cancer Research
- Solicitation number
- Not on record
About this file
This document is a SAM.gov Special Notice for a subcontracting opportunity at the Frederick National Laboratory for Cancer Research (FNLCR), focused on a malaria vaccine immunogenicity study. The notice, issued by Leidos Biomedical Research, Inc., seeks a subcontractor to provide laboratory animal support services for designing an RH5-based vaccine using a structure-based approach. The opportunity is specifically for laboratory animal husbandry and technical support services, including proper care and humane treatment of laboratory animals at the contract facility.
Key details include Notice ID S25-104, a response date of 7/9/2025, and NAICS code 541700. The opportunity is part of the National Cancer Institute's research initiatives, operated under Prime Contract No. 75N91019D00024 & HHSN261201500003I. The point of contact is Cody Wenner at cody.wenner@nih.gov, and interested parties can find additional information at https://frederick.cancer.gov/workwithus/solicitations. The notice emphasizes that this is an informational publication only, with no formal solicitation for offers, and any submissions become government property.
View the file
Other files
| File | Type | Posted |
|---|---|---|
| S25-104 RFP - Malaria Vaccine Immunogenicity.pdf |
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
SAM.gov Notice Details
Page 1 of 2 Rev. Feb 2024
P.O. Box B, Frederick, MD 21702-1201 • 301-846-1000
A subsidiary of
Required Notice Details for Posting Subcontracting Opportunities to SAM.gov
The following informational items are needed for posting notices to SAM.gov:
Notice ID: S25-104 RFP - Malaria Vaccine Immunogenicity
1. Request for Proposal in support of the National Cancer Institute (NCI)
2. Title: “NCI OA Special Notice of Subcontract Opportunity at the Frederick National Laboratory for Cancer
Research”
3. NAICS:
Primary: 541700 (or similar)
4. Response Date: 7/9/2025
5. Description: National Institutes of Health, National Cancer Institute, Frederick National Laboratory for Cancer Research Opportunities-Special Notice:
This Special Notice is not a formal Invitation for Bid (IFB), Request for Proposal (RFP), Request for Quotation (RFQ) nor any type of Solicitation for offers. In accordance with FAR 15.201(d), this Special Notice is intended FOR INFORMATIONAL PURPOSES ONLY in order to publicize the requirements of the Frederick National Laboratory for Cancer Research (FNLCR).
The FNLCR is a Government-Owned Contractor-Operated Federally Funded Research and Development Center (FFRDC) located at Fort Detrick, Maryland. The FNLCR partners with university, Government, and corporate scientists to speed the translation of laboratory research into new diagnostic tests and treatments for cancer and AIDS. FNLCR is a multi-program laboratory currently operated by Leidos Biomedical Research, Inc. (Leidos Biomed) for the National Cancer Institute (NCI) under Prime Contract No. 75N91019D00024 & HHSN261201500003I, which provides Operations and Technical Support (OTS) for the FNLCR.
The Government assumes no liability for reimbursement for any effort or associated costs to respond, nor for any information provided as a result of this Special Notice as no information is being requested. Please be advised that any submissions provided, despite that no information is requested, become Government property and will not be returned, nor will there be any ensuing discussions or debriefings.
Responses submitted to this Special Notice are not offers and cannot be accepted by the U.S. Government to form a binding contract. It is the responsibility of the interested parties to monitor this site and any sites referenced herein for additional information pertaining to business opportunities with the FNLCR, if any.
SAM.gov Notice Details
Page 2 of 2 Rev. Feb 2024
P.O. Box B, Frederick, MD 21702-1201 • 301-846-1000
A subsidiary of
In this study, we propose to design a better RH5-based vaccine by a structure-based approach. Independently, and not as an agent of the Government, the Subcontractor shall furnish the necessary management oversight and personnel for the performance of laboratory animal support services. The Subcontractor will be responsible for providing husbandry and technical support services required for the proper care, use and humane treatment of laboratory animals in their respective contract facility.
Leidos Biomedical Research, Inc. Point of Contact for a copy of Solicitation/RFP No: S25-104:
Cody Wenner at cody.wenner@nih.gov
For information concerning other opportunities with the FNLCR, please refer to:
https://frederick.cancer.gov/workwithus/solicitations
6. Archive Date: Automatic, 15 days after response date.
7. Allow Vendors To Add/Remove From Interested Vendors: No
8. Allow Vendors To View Interested Vendors List. This field is required. Choose "yes" if you want vendors to be able to view the interested vendors list: No
9. Attachments:
a. Secure - NO ATTACHMENTS
b. Package Type - Other
c. File Type - NO ATTACHMENTS
d. Description - NO ATTACHMENTS https://frederick.cancer.gov/workwithus/solicitations
File details come from the government source that posted it. Updated .